{
  "id": "515db020298dcd4e51000011",
  "type": "list",
  "question": "List all clinical trials of the polypill.",
  "ideal_answer": "'Use of a Multidrug Pill In Reducing cardiovascular Events' (UMPIRE) trial, European Clinical Trials database, as EudraCT: 2009-016278-34 and the Clinical Trials Registry, India as CTRI/2010/091/000250.\n'IMProving Adherence using Combination Therapy (IMPACT)', Australian New Zealand Clinical Trial Registry (ACTRN12606000067572).\n'Kanyini Guidelines Adherence with the Polypill (Kanyini-GAP)'\nPhase II study of the Polycap, double-blind, randomised trial, registered with ClinicalTrials.gov, number NCT00443794\nSecond Indian Polycap Study, TIPS-2\nCluster Randomized Usual Care vs Caduet Investigation Assessing Long-term-risk (CRUCIAL trial)\nGEMINI trial, 14-week, open-label trial conducted in 1220 patients from the USA\nGEMINI-Australia, Asia, Latin America, Africa/Middle East (AALA) study \nJEWEL study program, with JEWEL 1 conducted among 1138 patients from the UK and Canada and JEWEL 2 conducted in 1107 patients from Europe\nCAPABLE54, the Clinical Utility of Caduet in Simultaneously Achieving Blood Pressure and Lipid End Points , in the USA\nCUSP (The Caduet\u00ae in an Untreated Subject Population trial)\nTOGETHER trial\nA randomised controlled trial in seven countries \u2013 Australia, Brazil, India, Netherlands , New Zealand , United Kingdom  and United States.   Australian New Zealand Clinical Trials Registry (ACTRN 12607000099426)",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/15670547",
    "http://www.ncbi.nlm.nih.gov/pubmed/21682553",
    "http://www.ncbi.nlm.nih.gov/pubmed/22080542",
    "http://www.ncbi.nlm.nih.gov/pubmed/20334446",
    "http://www.ncbi.nlm.nih.gov/pubmed/16479100",
    "http://www.ncbi.nlm.nih.gov/pubmed/19339045",
    "http://www.ncbi.nlm.nih.gov/pubmed/22787067",
    "http://www.ncbi.nlm.nih.gov/pubmed/22162939",
    "http://www.ncbi.nlm.nih.gov/pubmed/15830173",
    "http://www.ncbi.nlm.nih.gov/pubmed/21777702",
    "http://www.ncbi.nlm.nih.gov/pubmed/20687931",
    "http://www.ncbi.nlm.nih.gov/pubmed/21647425",
    "http://www.ncbi.nlm.nih.gov/pubmed/23038750",
    "http://www.ncbi.nlm.nih.gov/pubmed/18227490",
    "http://www.ncbi.nlm.nih.gov/pubmed/21205325"
  ],
  "snippets": [
    {
      "text": "The 'Use of a Multidrug Pill In Reducing cardiovascular Events' (UMPIRE) trial assesses whether a polypill strategy (by combining aspirin, a statin and two blood pressure lowering agents) would improve adherence to guideline-indicated therapies and would lower both blood pressure and cholesterol, in people with established cardiovascular disease. UMPIRE, running in India and three European countries (England, Ireland and the Netherlands), is an open, randomised, controlled trial designed to include 1000 participants in India and 1000 in Europe, with a followup of 12-24 months.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23038750",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "UMPIRE is registered with the European Clinical Trials database, as EudraCT: 2009-016278-34 and the Clinical Trials Registry, India as CTRI/2010/091/000250. The trial was part of the 'Single Pill Against Cardiovascular Events (SPACE)' collaboration, which encompasses the 'IMProving Adherence using Combination Therapy (IMPACT)' and 'Kanyini Guidelines Adherence with the Polypill (Kanyini-GAP)' trials.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23038750",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "IMProving Adherence using Combination Therapy (IMPACT) is an open-label randomised controlled trial comparing a once-daily polypill containing four preventive medications with usual care",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21777702",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The trial is registered with the Australian New Zealand Clinical Trial Registry (ACTRN12606000067572).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21777702",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19339045",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "This study is registered with ClinicalTrials.gov, number NCT00443794",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19339045",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002986"
  ],
  "exact_answer": "Use of a Multidrug Pill In Reducing cardiovascular Events' (UMPIRE) trial, European Clinical Trials database\\, as EudraCT: 2009-016278-34 and the Clinical Trials Registry\\, India as CTRI/2010/091/000250., UMPIRE, IMProving Adherence using Combination Therapy (IMPACT)', Australian New Zealand Clinical Trial Registry (ACTRN12606000067572), IMPACT, Kanyini Guidelines Adherence with the Polypill (Kanyini-GAP), Phase II study of the Polycap, double-blind\\, randomised trial\\, registered with ClinicalTrials.gov\\, number NCT00443794, ndian Polycap Study, TIPS, TIPS, Cluster Randomized Usual Care vs Caduet Investigation Assessing Long-term-risk (CRUCIAL trial), CRUCIAL, GEMINI trial, 14-week\\, open-label trial conducted in 1220 patients from the USA, GEMINI, GEMINI-Australia, Asia\\, Latin America\\, Africa/Middle East (AALA) study, GEMINI-AALA, JEWEL 1 conducted among 1138 patients from the UK and Canada, JEWEL 1, JEWEL 2 conducted in 1107 patients from Europe, JEWEL 2, CAPABLE54, the Clinical Utility of Caduet in Simultaneously Achieving Blood Pressure and Lipid End Points\\, in the USA, CAPABLE54, CUSP (The Caduet\u00ae in an Untreated Subject Population trial), CUSP, TOGETHER trial, TOGETHER, A randomised controlled trial in seven countries \u2013 Australia, Brazil\\, India\\, Netherlands\\, New Zealand\\, United Kingdom and United States\\, Australian New Zealand Clinical Trials Registry (ACTRN 12607000099426), Second Indian Polycap Study, TIPS-2, TIPS-2,  Atorvastatin and Amlodipine in Patients with Elevated Lipids and Hypertension (AVALON) trial, AVALON, Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT), ASCOT"
}